People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Abrexa Pharmaceuticals, Inc. | — | Biotech / Pharma | Series B | $40.1M | $118.2M | 2025 |
David J. Hughley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David J. Hughley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Eckard Weber, M.D. | 1 | 5 |
| Lynne Rollins | 1 | 5 |
| NICOLE VITULLO | 1 | 4 |
| James J. Truchard | 1 | 1 |
| J. Ernest Villafranca | 1 | 1 |
| David J. Hugley | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.